Therapeutic strategies involving antimicrobial treatment of the central nervous system in large animals.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000187:drug effects; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000662:veterinary*; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006734:Horse Diseases / Q000188:drug therapy; D006736:Horses; D007239:Infections / Q000188:drug therapy / Q000662:veterinary*; D008581:Meningitis / Q000188:drug therapy / Q000662:veterinary; D011739:Pyrimethamine / Q000627:therapeutic use; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D005938:Glucocorticoids; D004121:Dimethyl Sulfoxide; D011739:Pyrimethamine